{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:12:29Z","timestamp":1790824349556,"version":"4.1.0"},"reference-count":76,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2016,7,13]],"date-time":"2016-07-13T00:00:00Z","timestamp":1468368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"BiogenIdec and the Swedish Research Council for Health, Working Life and Welfare","award":["2007-1762"],"award-info":[{"award-number":["2007-1762"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0159129","type":"journal-article","created":{"date-parts":[[2016,7,13]],"date-time":"2016-07-13T22:32:23Z","timestamp":1468449143000},"page":"e0159129","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":144,"title":["Cost of Illness of Multiple Sclerosis - A Systematic Review"],"prefix":"10.1371","volume":"11","author":[{"given":"Olivia","family":"Ernstsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Gyllensten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Alexanderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petter","family":"Tingh\u00f6g","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Friberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Norlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,7,13]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1600-0404.1997.tb00208.x","article-title":"Economic consequences of multiple sclerosis for Canadians","volume":"95","author":"CV Asche","year":"1997","journal-title":"Acta neurologica Scandinavica"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s10072-011-0578-4","article-title":"The direct cost of patients with multiple sclerosis: a survey from Italian MS centres","volume":"32","author":"P Berto","year":"2011","journal-title":"Neurological Science"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/PL00007858","article-title":"The costs of multiple sclerosis: a cross-sectional, multicenter cost-of-illness study in Italy","volume":"249","author":"MP Amato","year":"2002","journal-title":"Journal of neurology"},{"issue":"5 Pt 2","key":"ref4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00019053-199813050-00012","article-title":"The economic cost of multiple sclerosis in Sweden in 1994","volume":"13","author":"F Henriksson","year":"1998","journal-title":"PharmacoEconomics"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1191\/135245800678827545","article-title":"Cost and health related quality of life consequences of multiple sclerosis","volume":"6","author":"DT Grima","year":"2000","journal-title":"Multiple sclerosis"},{"key":"ref6","first-page":"379","article-title":"Methods for the economic evaluation of health care programmes","author":"M Drummond","year":"2005"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2165\/11532230-000000000-00000","article-title":"Economic burden of multiple sclerosis: a systematic review of the literature","volume":"28","author":"H Naci","year":"2010","journal-title":"PharmacoEconomics"},{"issue":"3","key":"ref8","first-page":"229","article-title":"The economics of multiple sclerosis. Distribution of costs and relationship to disease severity","volume":"15","author":"AN Grudzinski","year":"1999","journal-title":"PharmacoEconomics"},{"issue":"Suppl 1","key":"ref9","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1007\/s10198-005-0289-y","article-title":"Economic evidence in multiple sclerosis: a review","volume":"5","author":"G Kobelt","year":"2004","journal-title":"The European journal of health economics: HEPAC: health economics in prevention and care"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1191\/1352458505ms1137oa","article-title":"Cost of multiple sclerosis by level of disability: a review of literature","volume":"11","author":"MB Patwardhan","year":"2005","journal-title":"Multiple sclerosis"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1586\/14737167.6.2.145","article-title":"Economic burden of multiple sclerosis: what can we learn from cost-of-illness studies?","volume":"6","author":"E Orlewska","year":"2006","journal-title":"Expert review of pharmacoeconomics & outcomes research"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3111\/13696998.2013.778268","article-title":"The cost burden of multiple sclerosis in the United States: a systematic review of the literature","volume":"16","author":"G Adelman","year":"2013","journal-title":"Journal of medical economics"},{"issue":"8","key":"ref13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1590\/0004-282X20130082","article-title":"There is much to be learnt about the costs of multiple sclerosis in Latin America","volume":"71","author":"M Romano","year":"2013","journal-title":"Arquivos de neuro-psiquiatria"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3111\/13696998.2010.525989","article-title":"Contribution of intangible costs to the economic burden of multiple sclerosis","volume":"13","author":"A Wundes","year":"2010","journal-title":"Journal of medical economics"},{"issue":"13","key":"ref15","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.2165\/11538000-000000000-00000","article-title":"Pharmacoeconomic considerations in the treatment of multiple sclerosis","volume":"70","author":"J Sharac","year":"2010","journal-title":"Drugs"},{"issue":"9","key":"ref16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2165\/00023210-200418090-00002","article-title":"The cost of multiple sclerosis and the cost effectiveness of disease-modifying agents in its treatment","volume":"18","author":"CJ Phillips","year":"2004","journal-title":"CNS drugs"},{"issue":"2 Suppl","key":"ref17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1352458512441566","article-title":"Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries","volume":"18","author":"K Karampampa","year":"2012","journal-title":"Multiple sclerosis"},{"issue":"1","key":"ref18","first-page":"75","article-title":"How much is the cost of multiple sclerosis\u2014systematic literature review","volume":"67","author":"K Kolasa","year":"2013","journal-title":"Przeglad epidemiologiczny"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2307\/3349801","article-title":"Cost-of-illness methodology: a guide to current practices and procedures","volume":"60","author":"TA Hodgson","year":"1982","journal-title":"The Milbank Memorial Fund quarterly Health and society"},{"key":"ref20","article-title":"Global Economic Impact of Multiple Sclerosis","author":"MH A. Trisolini","year":"2010"},{"key":"ref21","article-title":"WHO Guide to identifying the economic consequences of disease and injury","year":"2009"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"6","author":"DL A. Moher","year":"2009","journal-title":"PLoS Med"},{"key":"ref23","article-title":"OECD. StatExtracts. PPPs and exchange rates","year":"2014"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.euroneuro.2011.05.001","article-title":"The socioeconomic consequences of multiple sclerosis: a controlled national study","volume":"22","author":"P Jennum","year":"2012","journal-title":"European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology"},{"issue":"Suppl 2","key":"ref25","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1007\/s10198-006-0379-5","article-title":"Costs and quality of life of multiple sclerosis in Sweden","volume":"7","author":"J Berg","year":"2006","journal-title":"The European journal of health economics: HEPAC: health economics in prevention and care"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1177\/1352458511424422","article-title":"Cost of multiple sclerosis in the Czech Republic: the COMS study","volume":"18","author":"J Blahova Dusankova","year":"2012","journal-title":"Multiple Sclerosis Journal"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10198-010-0286-7","article-title":"The cost of multiple sclerosis in Norway","volume":"13","author":"B Svendsen","year":"2012","journal-title":"The European journal of health economics: HEPAC: health economics in prevention and care"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"JF Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"1","key":"ref29","first-page":"26","article-title":"Health care costs of veterans with multiple sclerosis: implications for the rehabilitation of MS. VA Multiple Sclerosis Rehabilitation Study Group","volume":"74","author":"DN Bourdette","year":"1993","journal-title":"Archives of physical medicine and rehabilitation"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10072-011-0499-2","article-title":"Multiple sclerosis in Italy: cost-of-illness study","volume":"32","author":"F Patti","year":"2011","journal-title":"Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/jnnp.64.4.444","article-title":"Utilisation and cost of professional care and assistance according to disability of patients with multiple sclerosis in Flanders (Belgium)","volume":"64","author":"H Carton","year":"1998","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"e54756","DOI":"10.1371\/journal.pone.0054756","article-title":"Impact of mobility impairment on indirect costs and health-related quality of life in multiple sclerosis","volume":"8","author":"CI Coleman","year":"2013","journal-title":"PloS one"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1017\/S0317167100033448","article-title":"Burden of illness of multiple sclerosis: Part I: Cost of illness. The Canadian Burden of Illness Study Group","volume":"25","year":"1998","journal-title":"The Canadian journal of neurological sciences Le journal canadien des sciences neurologiques"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1472-6963-6-143","article-title":"Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability","volume":"6","author":"V Casado","year":"2006","journal-title":"BMC health services research"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1468-1331.2001.00169.x","article-title":"Costs, quality of life and disease severity in multiple sclerosis: a cross-sectional study in Sweden","volume":"8","author":"F Henriksson","year":"2001","journal-title":"European journal of neurology: the official journal of the European Federation of Neurological Societies"},{"key":"ref36","first-page":"181","article-title":"The cost of multiple sclerosis","volume":"8","author":"J MT Holmes","year":"1995","journal-title":"British Journal of Medical Economics"},{"issue":"2 Suppl","key":"ref37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/1352458512441566a","article-title":"Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from France","volume":"18","author":"E Johansson","year":"2012","journal-title":"Multiple sclerosis"},{"issue":"1","key":"ref38","first-page":"e11","article-title":"Treatment experience, burden, and unmet needs (TRIBUNE) in multiple sclerosis: the costs and utilities of MS patients in Canada","volume":"19","author":"K Karampampa","year":"2012","journal-title":"Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique"},{"issue":"2 Suppl","key":"ref39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/1352458512441566d","article-title":"Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from Spain","volume":"18","author":"K Karampampa","year":"2012","journal-title":"Multiple sclerosis"},{"issue":"2 Suppl","key":"ref40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1352458512441566b","article-title":"Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from Germany","volume":"18","author":"K Karampampa","year":"2012","journal-title":"Multiple sclerosis"},{"issue":"2 Suppl","key":"ref41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/1352458512441566c","article-title":"Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from Italy","volume":"18","author":"K Karampampa","year":"2012","journal-title":"Multiple sclerosis"},{"issue":"2 Suppl","key":"ref42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/1352458512441566e","article-title":"Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from the United Kingdom","volume":"18","author":"K Karampampa","year":"2012","journal-title":"Multiple sclerosis"},{"issue":"7","key":"ref43","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3111\/13696998.2013.807267","article-title":"Treatment experience, burden, and unmet needs (TRIBUNE) in Multiple Sclerosis study: the costs and utilities of MS patients in The Netherlands","volume":"16","author":"K Karampampa","year":"2013","journal-title":"Journal of medical economics"},{"issue":"Suppl 2","key":"ref44","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1007\/s10198-006-0378-6","article-title":"Costs and quality of life in multiple sclerosis in The Netherlands","volume":"7","author":"G Kobelt","year":"2006","journal-title":"The European journal of health economics: HEPAC: health economics in prevention and care"},{"issue":"Suppl 2","key":"ref45","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1007\/s10198-006-0383-9","article-title":"Costs and quality of life of multiple sclerosis in Switzerland","volume":"7","author":"G Kobelt","year":"2006","journal-title":"The European journal of health economics: HEPAC: health economics in prevention and care"},{"issue":"Suppl 2","key":"ref46","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1007\/s10198-006-0380-z","article-title":"Costs and quality of life of multiple sclerosis in the United Kingdom","volume":"7","author":"G Kobelt","year":"2006","journal-title":"The European journal of health economics: HEPAC: health economics in prevention and care"},{"issue":"Suppl 2","key":"ref47","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1007\/s10198-006-0382-x","article-title":"Costs and quality of life of multiple sclerosis in Austria","volume":"7","author":"G Kobelt","year":"2006","journal-title":"The European journal of health economics: HEPAC: health economics in prevention and care"},{"issue":"Suppl 2","key":"ref48","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1007\/s10198-006-0384-8","article-title":"Costs and quality of life of multiple sclerosis in Germany","volume":"7","author":"G Kobelt","year":"2006","journal-title":"The European journal of health economics: HEPAC: health economics in prevention and care"},{"issue":"Suppl 2","key":"ref49","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1007\/s10198-006-0385-7","article-title":"Costs and quality of life of multiple sclerosis in Italy","volume":"7","author":"G Kobelt","year":"2006","journal-title":"The European journal of health economics: HEPAC: health economics in prevention and care"},{"issue":"Suppl 2","key":"ref50","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1007\/s10198-006-0377-7","article-title":"Costs and quality of life for patients with multiple sclerosis in Belgium","volume":"7","author":"G Kobelt","year":"2006","journal-title":"The European journal of health economics: HEPAC: health economics in prevention and care"},{"issue":"Suppl 2","key":"ref51","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1007\/s10198-006-0381-y","article-title":"Costs and quality of life of multiple sclerosis in Spain","volume":"7","author":"G Kobelt","year":"2006","journal-title":"The European journal of health economics: HEPAC: health economics in prevention and care"},{"issue":"11","key":"ref52","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1212\/01.wnl.0000218309.01322.5c","article-title":"Costs and quality of life in multiple sclerosis: a cross-sectional study in the United States","volume":"66","author":"G Kobelt","year":"2006","journal-title":"Neurology"},{"issue":"6","key":"ref53","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/1352458509102771","article-title":"The long-term cost of multiple sclerosis in France and potential changes with disease-modifying interventions","volume":"15","author":"G Kobelt","year":"2009","journal-title":"Multiple sclerosis"},{"issue":"10","key":"ref54","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2165\/00019053-200826100-00005","article-title":"Multiple sclerosis in the UK: service use, costs, quality of life and disability","volume":"26","author":"P McCrone","year":"2008","journal-title":"PharmacoEconomics"},{"issue":"5 Pt 2","key":"ref55","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2165\/00019053-199813050-00013","article-title":"Economic evaluation of multiple sclerosis in the UK, Germany and France","volume":"13","author":"N Murphy","year":"1998","journal-title":"PharmacoEconomics"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2165\/11592160-000000000-00000","article-title":"Burden of a multiple sclerosis relapse: the patient's perspective","volume":"5","author":"M Oleen-Burkey","year":"2012","journal-title":"The patient"},{"issue":"1","key":"ref57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1468-1331.2004.00950.x","article-title":"A prospective study of the financial costs of multiple sclerosis at different stages of the disease","volume":"12","author":"E Orlewska","year":"2005","journal-title":"European journal of neurology: the official journal of the European Federation of Neurological Societies"},{"issue":"12","key":"ref58","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1177\/1352458513488230","article-title":"The economic impact of multiple sclerosis in Australia in 2010","volume":"19","author":"AJ Palmer","year":"2013","journal-title":"Multiple sclerosis"},{"issue":"6","key":"ref59","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000331043","article-title":"Economic burden in a German cohort of patients with multiple sclerosis","volume":"66","author":"JP Reese","year":"2011","journal-title":"European neurology"},{"issue":"1","key":"ref60","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/ane.12139","article-title":"Costs and quality of life in multiple sclerosis patients with spasticity","volume":"129","author":"J Svensson","year":"2014","journal-title":"Acta neurologica Scandinavica"},{"issue":"6","key":"ref61","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jocn.2006.08.007","article-title":"The cost of multiple sclerosis in Australia","volume":"14","author":"B Taylor","year":"2007","journal-title":"Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia"},{"issue":"9","key":"ref62","doi-asserted-by":"crossref","first-page":"703","DOI":"10.18553\/jmcp.2010.16.9.703","article-title":"All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States","volume":"16","author":"CV Asche","year":"2010","journal-title":"Journal of managed care pharmacy: JMCP"},{"issue":"6","key":"ref63","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1177\/1352458506073480","article-title":"An approach to estimating the intangible costs of multiple sclerosis according to disability in Catalonia, Spain","volume":"13","author":"V Casado","year":"2007","journal-title":"Multiple sclerosis"},{"key":"ref64","article-title":"Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I)","author":"UK Zettl","year":"2013","journal-title":"The European journal of health economics: HEPAC: health economics in prevention and care"},{"issue":"1","key":"ref65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jval.2010.10.022","article-title":"The economic burden of Medicare-eligible patients by multiple sclerosis type","volume":"14","author":"DM Gilden","year":"2011","journal-title":"Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research"},{"key":"ref66","first-page":"99","article-title":"The economics of multiple sclerosis: a cost of illness study","volume":"10","author":"LD Blumhardt","year":"1996","journal-title":"British Journal of Medical Economics"},{"issue":"1\u20132","key":"ref67","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jns.2013.04.007","article-title":"Direct and indirect cost burden associated with multiple sclerosis relapses: excess costs of persons with MS and their spouse caregivers","volume":"330","author":"H Parise","year":"2013","journal-title":"Journal of the neurological sciences"},{"issue":"6","key":"ref68","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s40273-013-0063-4","article-title":"Modelling the cost effectiveness of disease-modifying treatments for multiple sclerosis: issues to consider","volume":"31","author":"JP Thompson","year":"2013","journal-title":"PharmacoEconomics"},{"issue":"5","key":"ref69","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2796.2000.00749.x","article-title":"Direct medical costs for patients with type 2 diabetes in Sweden","volume":"248","author":"F Henriksson","year":"2000","journal-title":"J Intern Med"},{"issue":"2","key":"ref70","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10072-008-0868-7","article-title":"Cost of disorders of the brain in Italy","volume":"29","author":"M Pugliatti","year":"2008","journal-title":"Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"1","key":"ref71","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.healthpol.2005.07.016","article-title":"Cost-of-illness analysis. What room in health economics?","volume":"77","author":"R Tarricone","year":"2006","journal-title":"Health Policy"},{"issue":"1","key":"ref72","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1365-2796.2001.00852.x","article-title":"Cost of illness of adult diabetes mellitus underestimated if comorbidity is not considered","volume":"250","author":"A Norlund","year":"2001","journal-title":"J Intern Med"},{"issue":"4","key":"ref73","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/14034948980260040301","article-title":"Sickness absence: a review of performed studies with focused on levels of exposures and theories utilized","volume":"26","author":"K Alexanderson","year":"1998","journal-title":"Scandinavian journal of social medicine"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/14034950410021925","article-title":"Swedish Council on Technology Assessment in Health Care (SBU). Chapter 12. Future need for research","volume":"63","author":"K Alexanderson","year":"2004","journal-title":"Scandinavian journal of public health Supplement"},{"issue":"8","key":"ref75","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/jnnp.2006.090365","article-title":"Costs and quality of life of patients with multiple sclerosis in Europe","volume":"77","author":"G Kobelt","year":"2006","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"issue":"8","key":"ref76","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1177\/1352458507077941","article-title":"Estimation of the cost of MS in Europe: extrapolations from a multinational cost study","volume":"13","author":"P Sobocki","year":"2007","journal-title":"Multiple sclerosis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0159129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:32:15Z","timestamp":1588966335000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0159129"}},"subtitle":[],"editor":[{"given":"Robert Shin","family":"Fujinami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,7,13]]},"references-count":76,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,7,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0159129","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,13]]}}}